These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2316405)
21. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism. Nesbitt T; Drezner MK; Lobaugh B J Clin Invest; 1986 Jan; 77(1):181-7. PubMed ID: 3753708 [TBL] [Abstract][Full Text] [Related]
22. Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate. Moriwake T; Abribat T; Brazeau P; Ecarot B J Bone Miner Res; 1995 Nov; 10(11):1698-704. PubMed ID: 8592946 [TBL] [Abstract][Full Text] [Related]
23. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. Meyer RA; Tenenhouse HS; Meyer MH; Klugerman AH J Bone Miner Res; 1989 Aug; 4(4):523-32. PubMed ID: 2816501 [TBL] [Abstract][Full Text] [Related]
24. Increased renal 25-hydroxyvitamin D3-24-hydroxylase messenger ribonucleic acid and immunoreactive protein in phosphate-deprived Hyp mice: a mechanism for accelerated 1,25-dihydroxyvitamin D3 catabolism in X-linked hypophosphatemic rickets. Roy S; Martel J; Ma S; Tenenhouse HS Endocrinology; 1994 Apr; 134(4):1761-7. PubMed ID: 8137741 [TBL] [Abstract][Full Text] [Related]
25. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. Mawer EB; Hayes ME; Still PE; Davies M; Lumb GA; Palit J; Holt PJ J Bone Miner Res; 1991 Jul; 6(7):733-9. PubMed ID: 1950677 [TBL] [Abstract][Full Text] [Related]
26. Variable phosphate-mediated regulation of vitamin D metabolism in the murine hypophosphatemic rachitic/osteomalacic disorders. Davidai GA; Nesbitt T; Drezner MK Endocrinology; 1991 Mar; 128(3):1270-6. PubMed ID: 1999147 [TBL] [Abstract][Full Text] [Related]
27. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse. Cunningham J; Gomes H; Seino Y; Chase LR Endocrinology; 1983 Feb; 112(2):633-8. PubMed ID: 6600222 [TBL] [Abstract][Full Text] [Related]
28. Abnormal renal mitochondrial 25-hydroxyvitamin D3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse. Tenenhouse HS Endocrinology; 1983 Aug; 113(2):816-8. PubMed ID: 6683624 [TBL] [Abstract][Full Text] [Related]
29. Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L J Bone Miner Res; 1992 May; 7(5):523-30. PubMed ID: 1319665 [TBL] [Abstract][Full Text] [Related]
30. Vitamin D metabolite levels in normal children. Taylor AF; Norman ME Pediatr Res; 1984 Sep; 18(9):886-90. PubMed ID: 6333015 [TBL] [Abstract][Full Text] [Related]
31. Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse. Tenenhouse HS; Scriver CR Endocrinology; 1981 Aug; 109(2):658-60. PubMed ID: 6894727 [TBL] [Abstract][Full Text] [Related]
32. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218 [TBL] [Abstract][Full Text] [Related]
33. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse. Seino Y; Sierra RI; Ichikawa M; Avioli LV Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570 [TBL] [Abstract][Full Text] [Related]
34. 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. Markestad T; Aksnes L; Ulstein M; Aarskog D Am J Clin Nutr; 1984 Nov; 40(5):1057-63. PubMed ID: 6333810 [TBL] [Abstract][Full Text] [Related]
35. 25-Hydroxyvitamin D assays: Potential interference from other circulating vitamin D metabolites. Carter GD; Jones JC; Shannon J; Williams EL; Jones G; Kaufmann M; Sempos C J Steroid Biochem Mol Biol; 2016 Nov; 164():134-138. PubMed ID: 26718874 [TBL] [Abstract][Full Text] [Related]
36. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Marie PJ; Travers R; Glorieux FH Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410 [TBL] [Abstract][Full Text] [Related]
37. Vitamin D-dependent calcium binding proteins in the kidney and intestine of the X-linked hypophosphatemic mouse: changes with age and responses to 1,25-dihydroxycholecalciferol. Bruns ME; Christakos S; Huang YC; Meyer MH; Meyer RA Endocrinology; 1987 Jul; 121(1):1-6. PubMed ID: 3595516 [TBL] [Abstract][Full Text] [Related]
38. Impaired 24,25-dihydroxyvitamin D production in anephric human and pig. Horst RL; Littledike ET; Gray RW; Napoli JL J Clin Invest; 1981 Jan; 67(1):274-80. PubMed ID: 6969731 [TBL] [Abstract][Full Text] [Related]
39. Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice. Yamamoto T; Seino Y; Tanaka H; Yamaoka K; Kurose H; Ishida M; Yabuuchi H Endocrinology; 1988 Feb; 122(2):576-80. PubMed ID: 2828005 [TBL] [Abstract][Full Text] [Related]
40. Metabolites of vitamin D in normal and X-linked hypophosphatemic mice. Meyer RA; Meyer MH; Gray RW Calcif Tissue Int; 1984 Dec; 36(6):662-7. PubMed ID: 6442201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]